Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir R.M.W. HoetelmansC.H.W. KoksD.M. Burger Legacy Pages: 159 - 175
Pharmacoeconomics and therapeutic drug monitoring. J. Lyle BootmanDonald L. Harrison OriginalPaper Pages: 178 - 181
Scenario analysis of the future of clinical pharmacy. Hubert LeufkensYechiel HeksterSteve Hudson OriginalPaper Pages: 182 - 185
Good Practice in the Postmarketing Surveillance of Medicines. R.H.B. Meyboom OriginalPaper Pages: 186 - 190
Dosage recommendation of vancomycin during haemodialysis with highly permeable membranes. J. ZoerA.M. Schrander-van der MeerW.T. van Dorp OriginalPaper Pages: 191 - 196
Stability of nystatin in mouthrinses; effect of pH, temperature, concentration and colloidal silver addition, studied using an in vitro antifungal activity. N. VermerieC. MalbrunotP. Arnaud OriginalPaper Pages: 197 - 201
Evaluation of drug use and cost of hospital care for aids patients between 1990 and 1994. F. PeyronS. Galliano-Di BernardoJ. Moreau OriginalPaper Pages: 202 - 207
Falsification of Thai dianabol. P.-H.M. van der KuyP.M. HooymansB.J. Looij jr Legacy Pages: 208 - 209